A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
K36 Therapeutics, Inc.
Advanced Accelerator Applications
Revolution Medicines, Inc.
Endocyte
Poseida Therapeutics, Inc.
Aragon Pharmaceuticals, Inc.
Revolution Medicines, Inc.